2.3 million people have died from COVID-19 since the start of the pandemic.But the ability of healthcare professionals to save the lives of patients in intensive care with the illness has improved markedly over the past year.
In June 2020, a study revealed that the steroid dexamethasone reduced overall mortality among patients hospitalized with COVID-19 by 17%.Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.Other research found that drugs that showed early promise, including hydroxychloroquine, azithromycin, and remdesivir, had no clear benefit for reducing mortality.In parallel, intensive care doctors have refined oxygen and fluid therapies, while.